胃内滞留型ドラッグデリバリーシステムの世界市場

胃内滞留型ドラッグデリバリーシステムの世界市場は2030年までに199億米ドルに達する見込み

2024年に151億米ドルと推定される胃内滞留型ドラッグデリバリーシステムの世界市場は、2024年から2030年にかけてCAGR 4.6%で成長し、2030年には199億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである浮遊式ドラッグデリバリーシステムは、CAGR 3.4%を記録し、分析期間終了時には67億米ドルに達すると予測されます。拡張型ドラッグデリバリーシステム分野の成長率は、分析期間中CAGR 6.2%と推定されます。

米国市場は41億米ドルと推定、中国はCAGR 7.1％で成長予測

米国の胃内滞留型ドラッグデリバリーシステム市場は、2024年に41億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに38億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは7.1%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.3%と4.6%と予測されています。欧州では、ドイツがCAGR 2.9%で成長すると予測されています。

世界の胃内滞留型ドラッグデリバリーシステム市場- 主要動向と促進要因のまとめ

なぜ胃内滞留型ドラッグデリバリーシステムが経口薬治療に変革をもたらすのか？

胃内滞留型ドラッグデリバリーシステム（GRDDS）は、胃での薬物の長時間滞留を可能にし、吸収とバイオアベイラビリティを改善することで、経口薬物投与に革命をもたらしました。これらのシステムは、上部消化管での吸収ウィンドウが狭い薬物や、アルカリ性条件下で分解される薬物にとって特に有益です。胃内滞留時間を延長することで、GRDDSは薬剤の治療効果を高めると同時に投与回数を減らし、患者のコンプライアンス向上につながります。

浮遊性、生体接着性、膨潤性、膨張性ドラッグデリバリーシステムなどの胃内滞留性技術の開発は、製薬会社に薬剤の性能を最適化する革新的なソリューションを提供してきました。浮遊型ドラッグデリバリーシステム（FDDS）は最も広く使用されているシステムの一つで、胃液中で浮遊性を維持する低密度の製剤を利用し、持続的な薬物放出を保証します。同様に、生体接着システムは胃粘膜に付着し、薬物の吸収部位との接触時間を延長します。製薬会社が薬物の溶解性と放出制御メカニズムの改善に注力する中、GRDDSは最新の経口薬製剤の不可欠な一部となりつつあります。

どの治療分野が胃内滞留型ドラッグデリバリーシステムの需要を牽引していますか？

胃内滞留型ドラッグデリバリーシステムは、胃腸障害、糖尿病、心血管疾患、感染症など、複数の治療分野で広く使用されています。GERDや消化性潰瘍の治療に一般的に使用されるプロトンポンプ阻害薬（PPI）やH2受容体拮抗薬は、最適な効果を得るために長時間の胃内滞留を必要とするため、GRDDSから大きな恩恵を受けます。同様に、ヘリコバクター・ピロリの除菌療法に使用されるアモキシシリンやメトロニダゾールなどの抗生物質も、除菌率を高めるために胃内滞留性製剤を活用しています。

糖尿病管理の分野では、上部消化管での吸収ウィンドウが限られているメトホルミンなどの薬剤のバイオアベイラビリティをGRDDSが改善しています。スタチンやベータ遮断薬などの心血管治療薬も、薬剤放出の制御と患者の服薬アドヒアランスを向上させるため、胃内滞留性技術を用いた製剤化が進んでいます。GRDDSの需要は、疼痛管理および中枢神経系（CNS）医薬品の分野でさらに拡大しており、そこでは薬物の徐放化によって副作用を最小限に抑え、治療成績を向上させることができます。

どのような技術革新が胃内滞留性ドラッグデリバリーを強化しているのでしょうか？

ポリマーサイエンスとナノテクノロジーの進歩により、胃内滞留型ドラッグデリバリーシステムの有効性が大幅に改善されました。スマートポリマーをベースとした製剤が開発され、胃内での膨潤、膨張、固着が制御され、薬物放出速度が最適化されています。さらに、ナノ製剤は難水溶性薬物の溶解性と吸収性を高め、より効率的なドラッグデリバリーを可能にしています。

もうひとつの大きな技術革新は、GRDDSにマイクロエレクトロニクス・モニタリングを組み込むことで、薬物放出と胃内滞留をリアルタイムで追跡できるようにしたことです。センサーを組み込んだスマート錠剤は、薬物吸収パターンに関するデータを医師に提供し、個別化治療アプローチを改善することができます。3Dプリンティング技術もまた、カスタマイズされた胃内滞留性薬剤製剤を開発するために研究されており、薬剤放出プロファイルの精密な制御を可能にしています。こうした技術的進歩により、GRDDSはより効果的で適応性が高く、患者に優しいものとなっています。

胃内滞留型ドラッグデリバリーシステム市場の成長を促進している要因は？

胃内滞留型ドラッグデリバリーシステム市場の成長は、胃腸疾患の有病率の増加、放出制御型製剤に対する需要の高まり、ポリマーベースのデリバリー技術の進歩など、いくつかの要因によってもたらされます。バイオアベイラビリティを向上させた長期投薬が必要とされる老人人口の増加も、市場拡大に寄与しています。

製薬業界が患者中心の製剤に重点を置くようになったことで、GRDDSの研究開発への投資が増加しています。さらに、特に糖尿病や心血管障害などの慢性疾患の治療において、胃内滞留性製剤の規制当局による承認が商業化を後押ししています。バイオ医薬品研究の拡大と革新的なドラッグデリバリー機構の採用が、市場の成長をさらに後押ししています。製薬企業が新たな薬物製剤の探求を続ける中、胃内滞留型ドラッグデリバリーシステムの需要は拡大し、経口薬物療法の将来が形作られると予想されます。

セグメント

タイプ（浮遊型ドラッグデリバリーシステム、拡張型ドラッグデリバリーシステム、生体接着型ドラッグデリバリーシステム、高密度システム、その他の胃内滞留型ドラッグデリバリーシステム）、投与量（錠剤投与量、カプセル投与量、ゲル投与量、液体投与量、その他の投与量）、流通チャネル（病院薬局流通チャネル、小売薬局流通チャネル、オンライン薬局流通チャネル）

調査対象企業の例

• AbbVie Inc.
• Alcon Inc.
• AptarGroup, Inc.
• Ashland Global Holdings Inc.
• AstraZeneca plc
• Cadila Pharmaceuticals
• Catalent, Inc.
• Colorcon, Inc.
• Evonik Industries AG
• Evotec SE
• F. Hoffmann-La Roche AG
• GlaxoSmithKline plc
• Lonza Group AG
• Lupin Limited
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi S.A.
• Sun Pharmaceutical Industries Ltd.
• Torrent Pharmaceuticals Ltd.

AIインテグレーション

私たちは、検証された専門家のコンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Gastroretentive Drug Delivery Systems Market to Reach US$19.9 Billion by 2030

The global market for Gastroretentive Drug Delivery Systems estimated at US$15.1 Billion in the year 2024, is expected to reach US$19.9 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Floating Drug Delivery System, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$6.7 Billion by the end of the analysis period. Growth in the Expandable Drug Delivery System segment is estimated at 6.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.1 Billion While China is Forecast to Grow at 7.1% CAGR

The Gastroretentive Drug Delivery Systems market in the U.S. is estimated at US$4.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.8 Billion by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Gastroretentive Drug Delivery Systems Market - Key Trends & Drivers Summarized

Why Are Gastroretentive Drug Delivery Systems Transforming Oral Drug Therapies?

Gastroretentive drug delivery systems (GRDDS) have revolutionized oral drug administration by enabling prolonged retention of drugs in the stomach, improving absorption and bioavailability. These systems are particularly beneficial for drugs with a narrow absorption window in the upper gastrointestinal tract or those that degrade in alkaline conditions. By ensuring extended gastric residence time, GRDDS enhance the therapeutic efficacy of drugs while reducing dosing frequency, leading to improved patient compliance.

The development of gastroretentive technologies, such as floating, bioadhesive, swelling, and expandable drug delivery systems, has provided pharmaceutical companies with innovative solutions to optimize drug performance. Floating drug delivery systems (FDDS) are among the most widely used, utilizing low-density formulations that remain buoyant in gastric fluids, ensuring sustained drug release. Similarly, bioadhesive systems adhere to the gastric mucosa, prolonging drug contact time with absorption sites. As pharmaceutical companies focus on improving drug solubility and controlled release mechanisms, GRDDS are becoming an integral part of modern oral drug formulations.

Which Therapeutic Areas Are Driving Demand for Gastroretentive Drug Delivery Systems?

Gastroretentive drug delivery systems are widely used across multiple therapeutic areas, including gastrointestinal disorders, diabetes, cardiovascular diseases, and infectious diseases. Proton pump inhibitors (PPIs) and H2-receptor antagonists, commonly used for GERD and peptic ulcer treatment, benefit significantly from GRDDS, as they require prolonged gastric retention for optimal effectiveness. Similarly, antibiotics such as amoxicillin and metronidazole used in Helicobacter pylori eradication therapy leverage gastroretentive formulations to enhance bacterial eradication rates.

In the diabetes management sector, GRDDS are improving the bioavailability of drugs such as metformin, which has a limited absorption window in the upper GI tract. Cardiovascular drugs, including statins and beta-blockers, are also being formulated with gastroretentive technologies to improve controlled drug release and patient adherence. The demand for GRDDS is further expanding in the pain management and central nervous system (CNS) drug sectors, where sustained drug release can minimize side effects and improve therapeutic outcomes.

What Technological Innovations Are Enhancing Gastroretentive Drug Delivery?

Advancements in polymer science and nanotechnology have significantly improved the effectiveness of gastroretentive drug delivery systems. Smart polymer-based formulations are being developed to achieve controlled swelling, expansion, and adherence within the stomach, optimizing drug release kinetics. Additionally, nano-formulations are enhancing the solubility and absorption of poorly water-soluble drugs, ensuring more efficient drug delivery.

Another major innovation is the incorporation of microelectronic monitoring in GRDDS, allowing real-time tracking of drug release and gastric retention. Smart pills with embedded sensors can provide physicians with data on drug absorption patterns, improving personalized treatment approaches. 3D printing technology is also being explored to develop customized gastroretentive drug formulations, enabling precise control over drug release profiles. These technological advancements are making GRDDS more effective, adaptable, and patient-friendly.

What Factors Are Fueling the Growth of the Gastroretentive Drug Delivery Systems Market?

The growth in the gastroretentive drug delivery systems market is driven by several factors, including the increasing prevalence of gastrointestinal diseases, rising demand for controlled-release drug formulations, and advancements in polymer-based delivery technologies. The growing geriatric population, which requires long-term medication with improved bioavailability, has also contributed to market expansion.

The pharmaceutical industry’s focus on patient-centric drug formulations has led to increased investment in GRDDS research and development. Additionally, regulatory approvals for gastroretentive formulations are driving their commercialization, particularly in the treatment of chronic diseases such as diabetes and cardiovascular disorders. The expansion of biopharmaceutical research and the adoption of innovative drug delivery mechanisms are further propelling market growth. As pharmaceutical companies continue to explore novel drug formulations, the demand for gastroretentive drug delivery systems is expected to grow, shaping the future of oral drug therapies.

SCOPE OF STUDY:

The report analyzes the Gastroretentive Drug Delivery Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems, Other Gastroretentive Drug Delivery Systems); Dosage (Tablets Dosage, Capsule Dosage, Gel Dosage, Liquid Dosage, Other Dosages); Distribution Channel (Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• AbbVie Inc.
• Alcon Inc.
• AptarGroup, Inc.
• Ashland Global Holdings Inc.
• AstraZeneca plc
• Cadila Pharmaceuticals
• Catalent, Inc.
• Colorcon, Inc.
• Evonik Industries AG
• Evotec SE
• F. Hoffmann-La Roche AG
• GlaxoSmithKline plc
• Lonza Group AG
• Lupin Limited
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi S.A.
• Sun Pharmaceutical Industries Ltd.
• Torrent Pharmaceuticals Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Gastroretentive Drug Delivery Systems - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Need for Enhanced Oral Bioavailability of Low-Solubility Drugs Drives Adoption of Gastroretentive Delivery Systems
  • Increased Focus on Site-Specific Drug Release Enhances the Business Case for Gastroretentive Platforms
  • Growing Prevalence of Gastric Disorders and Chronic Conditions Spurs Demand for Targeted Gastric Drug Delivery
  • Technological Advancements in Floating, Mucoadhesive, and Expandable Systems Improve Gastric Retention Efficiency
  • Expansion of Controlled and Sustained Release Drug Markets Strengthens Use of Gastroretentive Formulations
  • OEM Innovation in Polymer-Based Carriers and Swellable Systems Enhances Formulation Stability
  • Shift Toward Patient-Centric Oral Therapies Supports Development of Gastroretentive Drug Systems
  • Rising Demand for Once-Daily Dosing and Reduced Side Effects Drives Innovation in Gastric Retention Mechanisms
  • Emergence of Gastroretentive Systems as Lifecycle Extension Tools for Off-Patent Drugs Creates Growth Opportunities
  • Integration of Predictive Modeling and Simulation Tools Improves GRDDS Design and Development Timelines
  • Growing Research in Helicobacter pylori Eradication and Localized GI Therapies Increases Application Scope
  • Increasing FDA Approvals of GRDDS-Based Formulations Validates Clinical Efficacy and Commercial Viability
  • Demand for Oral Delivery of Peptides and Macromolecules Spurs Interest in Advanced Gastric Retentive Technologies
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Gastroretentive Drug Delivery Systems Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Gastroretentive Drug Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Gastroretentive Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Floating Drug Delivery System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Floating Drug Delivery System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Floating Drug Delivery System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Expandable Drug Delivery System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Expandable Drug Delivery System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Expandable Drug Delivery System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Bioadhesive Drug Delivery System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Bioadhesive Drug Delivery System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Bioadhesive Drug Delivery System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for High Density Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for High Density Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for High Density Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Gastroretentive Drug Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Gastroretentive Drug Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Gastroretentive Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Dosages by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Dosages by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Dosages by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Tablets Dosage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Tablets Dosage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Tablets Dosage by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Capsule Dosage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Capsule Dosage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Capsule Dosage by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Gel Dosage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Gel Dosage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Gel Dosage by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Liquid Dosage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Liquid Dosage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Liquid Dosage by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Hospital Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Retail Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Online Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Online Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Online Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• JAPAN
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• CHINA
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 71: China Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• EUROPE
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Gastroretentive Drug Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Gastroretentive Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• FRANCE
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 92: France Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• GERMANY
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 119: UK Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Gastroretentive Drug Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Gastroretentive Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• INDIA
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 176: India Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Gastroretentive Drug Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Gastroretentive Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Gastroretentive Drug Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Gastroretentive Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• AFRICA
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030

IV. COMPETITION